Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects. 1991

N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
Department of Medicine, University of Toronto, Ontario, Canada.

The relation between inhalation of ambient concentrations of ozone and airway reactivity to inhaled allergens may be important in asthma, since both agents can produce inflammatory changes in the airways. Seven asthmatic patients (mean age 40 [SD 13] years), with seasonal symptoms of asthma and positive skin tests for ragweed or grass, took part in a study to investigate whether exposure to low concentrations of ozone potentiates the airway allergic response. The patients were studied during 4 separate weeks in the winter. In each week there were 3 study days: on days 1 and 3 methacholine challenges were carried out; and on day 2 the subject received one of four combined challenges in a single-blind design--air breathing followed by inhalation of allergen diluent (placebo); ozone followed by inhalation of allergen diluent; air followed by allergen; or ozone followed by allergen. The ozone concentration was 0.12 ppm during 1 h of tidal breathing at rest, and allergens were inhaled until the forced expiratory volume in 1 s (FEV1) had fallen by 15% (PC15). There were no significant differences in baseline FEV1 after exposure to ozone but PC15 was significantly reduced when allergen was preceded by ozone inhalation: the mean PC15 after air was 0.013 (SD 0.017) mg/ml compared with 0.0056 (0.0062) mg/ml after ozone (p = 0.042). Thus, low ozone concentrations, similar to those commonly occurring in urban areas, can increase the bronchial responsiveness to allergen in atopic asthmatic subjects. This effect does not seem to be the result of changes in baseline airway function.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010126 Ozone The unstable triatomic form of oxygen, O3. It is a powerful oxidant that is produced for various chemical and industrial uses. Its production is also catalyzed in the ATMOSPHERE by ULTRAVIOLET RAY irradiation of oxygen or other ozone precursors such as VOLATILE ORGANIC COMPOUNDS and NITROGEN OXIDES. About 90% of the ozone in the atmosphere exists in the stratosphere (STRATOSPHERIC OZONE). Ground Level Ozone,Low Level Ozone,Tropospheric Ozone,Level Ozone, Ground,Level Ozone, Low,Ozone, Ground Level,Ozone, Low Level,Ozone, Tropospheric
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000393 Air Pollutants Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS. Air Pollutant,Air Pollutants, Environmental,Environmental Air Pollutants,Environmental Pollutants, Air,Air Environmental Pollutants,Pollutant, Air,Pollutants, Air,Pollutants, Air Environmental,Pollutants, Environmental Air
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen

Related Publications

N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
June 2004, Chest,
N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
May 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
September 1999, American journal of respiratory and critical care medicine,
N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
January 1994, Lancet (London, England),
N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
December 1997, American journal of respiratory and critical care medicine,
N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
September 1998, Chest,
N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
July 1984, Clinical allergy,
N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
February 1993, Respiratory medicine,
N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
February 2007, Environmental health perspectives,
N A Molfino, and S C Wright, and I Katz, and S Tarlo, and F Silverman, and P A McClean, and J P Szalai, and M Raizenne, and A S Slutsky, and N Zamel
February 1989, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!